DOK6 promoter methylation serves as a potential biomarker affecting prognosis in de novo acute myeloid leukemia

BACKGROUND: Downstream of tyrosine kinase 6 (DOK6), which is specifically expressed in the nervous system, was previously recognized as an adapter only in neurite outgrowth. Recent studies also demonstrated the potential role of DOK6 in solid tumors such as gastric cancer and breast cancer. However,...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancer Med
Main Authors: Sun, Guo‐Kang, Tang, Li‐Juan, Zhou, Jing‐Dong, Xu, Zi‐Jun, Yang, Lan, Yuan, Qian, Ma, Ji‐Chun, Liu, Xing‐Hui, Lin, Jiang, Qian, Jun, Yao, Dong‐Ming
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2019
Teme:
Cancer Biology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6797566/
https://ncbi.nlm.nih.gov/pubmed/31486300
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2540
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki